Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.08
+0.10 (1.43%)
At close: Nov 26, 2025, 4:00 PM EST
7.33
+0.25 (3.53%)
After-hours: Nov 26, 2025, 7:45 PM EST
Sagimet Biosciences Employees
Sagimet Biosciences had 14 employees as of December 31, 2024. The number of employees increased by 4 or 40.00% compared to the previous year.
Employees
14
Change (1Y)
4
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$4,119,357
Market Cap
230.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14 | 4 | 40.00% |
| Dec 31, 2023 | 10 | 0 | - |
| Dec 31, 2022 | 10 | 3 | 42.86% |
| Dec 31, 2020 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SGMT News
- 6 days ago - Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference - GlobeNewsWire
- 8 days ago - Sagimet Biosciences Advances Denifanstat: Q3 Earnings And Upcoming Catalysts - Seeking Alpha
- 16 days ago - Sagimet Biosciences Presents Two Denifanstat Posters at AASLD—The Liver Meeting® 2025 - GlobeNewsWire
- 4 weeks ago - Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference - GlobeNewsWire
- 6 weeks ago - Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration - PRNewsWire
- 7 weeks ago - Denifanstat Advances: Sagimet Builds Momentum Toward 2026 Readouts - Seeking Alpha
- 7 weeks ago - Sagimet Biosciences Announces Upcoming Presentation at AASLD—The Liver Meeting® 2025 - GlobeNewsWire